Protests Continue in Cyprus: Countdown (3/27)

March 27 (Bloomberg) -- On today's "Countdown," Bloomberg's Mark Barton tracks the breaking business news and top stories in the lead-up to the opening of the European markets. (Source: Bloomberg)
Inside Johnson & Johnson's Earnings Beat
00:17 - Johnson & Johnson beat analysts’ estimates for third-quarter profit as a lower tax rate helped the world’s biggest maker of health-care products overcome slightly weaker-than-projected sales for key drugs such as Remicade. Gabelli & Co.'s Jeff Jonas and Bloomberg's Cynthia Koons weigh in on "Bloomberg Markets." Jonas owns no stock in J&J. (Source: Bloomberg)
  • Have We Hit the Bottom in Commodity Prices?
  • Why Market Correction Didn't Change the M&A Pipeline
  • Norway's Oil: What'd You Miss?: (Full Show 10/12)